Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs

Vaccine

Volumn 33, Issue 47, 2015, Pages 6430-6435

  Savitz, David A ^a,b   Fell, Deshayne B ^c   Ortiz, Justin R ^d   Bhat, Niranjan ^e  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e PATH   (United States)

Author keywords

Fetal growth; Influenza vaccination; Pregnancy; Preterm birth

Indexed keywords

INFLUENZA VACCINE;

ANALYTIC METHOD; ARTICLE; FEMALE; FETUS GROWTH; HOSPITALIZATION; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INTRAUTERINE GROWTH RETARDATION; MEDICAL RESEARCH; METHODOLOGY; PATIENT HARM; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE ASSESSMENT; SMALL FOR DATE INFANT; COMPLICATION; FETAL GROWTH RETARDATION; IMMUNOLOGY; INFLUENZA, HUMAN; PREGNANCY; PREMATURE BIRTH;

FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH;

EID: 84948109762     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.08.041     Document Type: Article

References (42)

1. World Health Organization Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012, 47:461-476.
2. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564. 10.1056/NEJMoa0708630.
3. Madhi S.A., Cutland C.L., Kuwanda L., Weinberg A., Hugo A., Jones S., et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014, 371:918-931. 10.1056/NEJMoa1401480.
4. Moro P.L., Broder K., Zheteyeva Y., Revzina N., Tepper N., Kissin D., et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2011, 205:473.e1-473.e9. 10.1016/j.ajog.2011.06.047.
5. Fell D.B., Platt R.W., Lanes A., Wilson K., Kaufman J.S., Basso O., et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 2015, 122:17-26. 10.1111/1471-0528.12977.
6. Bratton K.N., Wardle M.T., Orenstein W.A., Omer S.B. Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis 2015, 60:e11-e19. 10.1093/cid/ciu915.
7. Global Alliance for Vaccines and Immunisation (GAVI). Final Vaccine Investment Strategy Analysis 2013: Maternal Influenza 2013:12. [accessed 28.05.2015]. http://www.gavi.org/about/strategy/vaccine-investment-strategy/.
8. World Health Organization. WHO Taskforce to Evaluate Influenza Data to Inform Vaccine Impact and Economic Modelling 2014. [accessed 07.06.15]. http://www.who.int/entity/immunization/sage/meetings/2015/april/1_Interim_Report_WHO_Initiative_Vaccine_Research_24March_2015_execSAGE.pdf?ua=1.
9. Fell D.B., Dodds L., Macdonald N.E., Allen V.M., McNeil S. Influenza vaccination and fetal and neonatal outcomes. Expert Rev Vaccines 2013, 12:1417-1430. 10.1586/14760584.2013.851607.
10. Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1) - United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep 2011, 60:1193-1196.
11. Xu R., Luo Y., Chambers C. Assessing the effect of vaccine on spontaneous abortion using time-dependent covariates Cox models. Pharmacoepidemiol Drug Saf 2012, 844-850. 10.1002/pds.3301.
12. Matok I., Azoulay L., Yin H., Suissa S. Immortal time bias in observational studies of drug effects in pregnancy. Birth Defects Res A: Clin Mol Teratol 2014, 100:658-662. 10.1002/bdra.23271.
13. Håberg S.E., Trogstad L., Gunnes N., Wilcox A.J., Gjessing H.K., Samuelsen S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013, 368:333-340. 10.1056/NEJMoa1207210.
14. Kay A.W., Blish C.A. Immunogenicity and clinical efficacy of influenza vaccination in pregnancy. Front Immunol 2015, 6:289. 10.3389/fimmu.2015.00289.
15. Manske J.M. Efficacy and effectiveness of maternal influenza vaccination during pregnancy: a review of the evidence. Matern Child Health J 2014, 18:1599-1609. 10.1007/s10995-013-1399-2.
16. Thompson M.G., Li D.-K., Shifflett P., Sokolow L.Z., Ferber J.R., Kurosky S., et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis 2014, 58:449-457. 10.1093/cid/cit750.
17. Hartert T.V., Neuzil K.M., Shintani A.K., Mitchel E.F., Snowden M.S., Wood L.B., et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003, 189:1705-1712. 10.1016/S0002-9378(03)00857-3.
18. McNeil S.A., Dodds L.A., Fell D.B., Allen V.M., Halperin B.A., Steinhoff M.C., et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol 2011, 204:S54-S57. 10.1016/j.ajog.2011.04.031.
19. Martin A., Cox S., Jamieson D.J., Whiteman M.K., Kulkarni A., Tepper N.K. Respiratory illness hospitalizations among pregnant women during influenza season, 1998-2008. Matern Child Health J 2013, 17:1325-1331. 10.1007/s10995-012-1135-3.
20. Pierce M., Kurinczuk J.J., Spark P., Brocklehurst P., Knight M. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011, 342:d3214. 10.1136/bmj.d3214.
21. Doyle T.J., Goodin K., Hamilton J.J. Maternal and neonatal outcomes among pregnant women with 2009 pandemic influenza A(H1N1) illness in Florida, 2009-2010: a population-based cohort study. PLoS ONE 2013, 8:e79040. 10.1371/journal.pone.0079040.
22. Naresh A., Fisher B.M., Hoppe K.K., Catov J., Xu J., Hart J., et al. A multicenter cohort study of pregnancy outcomes among women with laboratory-confirmed H1N1 influenza. J Perinatol 2013, 33:939-943. 10.1038/jp.2013.110.
23. Hansen C., Desai S., Bredfeldt C., Cheetham C., Gallagher M., Li D-K., et al. A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis 2012, 206:1260-1268. 10.1093/infdis/jis488.
24. Bánhidy F., Acs N., Puhó E.H., Czeizel A.E. Maternal acute respiratory infectious diseases during pregnancy and birth outcomes. Eur J Epidemiol 2008, 23:29-35. 10.1007/s10654-007-9206-2.
25. Morken N-H., Gunnes N., Magnus P., Jacobsson B. Risk of spontaneous preterm delivery in a low-risk population: the impact of maternal febrile episodes, urinary tract infection, pneumonia and ear-nose-throat infections. Eur J Obstet Gynecol Reprod Biol 2011, 159:310-314. 10.1016/j.ejogrb.2011.08.006.
26. Nieto-Pascual L., Arjona-Berral J.E., Marín-Martín E.M., Muñoz-Gomariz E., Ilich I., Castelo-Branco C. Early prophylactic treatment in pregnant women during the 2009-2010 H1N1 pandemic: obstetric and neonatal outcomes. J Obstet Gynaecol 2013, 33:128-134. 10.3109/01443615.2012.740526.
27. Keller-Stanislawski B., Englund J.A., Kang G., Mangtani P., Neuzil K., Nohynek H., et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 2014, 32:7057-7064. 10.1016/j.vaccine.2014.09.052.
28. Omer S.B., Goodman D., Steinhoff M.C., Rochat R., Klugman K.P., Stoll B.J., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011, 8:e1000441. 10.1371/journal.pmed.1000441.
29. Steinhoff M.C., Omer S.B., Roy E., El Arifeen S., Raqib R., Dodd C., et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012, 184:645-653. 10.1503/cmaj.110754.
30. Strand L.B., Barnett A.G., Tong S. The influence of season and ambient temperature on birth outcomes: a review of the epidemiological literature. Environ Res 2011, 111:451-462. 10.1016/j.envres.2011.01.023.
31. Bhutta Z.A., Das J.K., Bahl R., Lawn J.E., Salam R.A., Paul V.K., et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?. Lancet 2014, 384:347-370. 10.1016/S0140-6736(14)60792-3.
32. Levine G.A., Matheson A., Batra M., Lewis A., Walson J., John-Stewart G. Interventions in Pregnancy to Improve Birth Weight, Prevent Low Birth Weight, Small-for-Gestational-Age and Prematurity: Report to the World Health Organization Initiative for Vaccine Research 2014, Seattle, Washington.
33. Ludvigsson J.F., Zugna D., Cnattingius S., Richiardi L., Ekbom A., Ortqvist A., et al. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol 2013, 10.1007/s10654-013-9813-z.
34. Pasternak B., Svanström H., Mølgaard-Nielsen D., Krause T.G., Emborg H-D., Melbye M., et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012, 308:165-174. 10.1001/jama.2012.6131.
35. Nordin J.D., Kharbanda E.O., Vazquez Benitez G., Lipkind H., Vellozzi C., Destefano F. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 2014, 164. 1051.e2-1057.e2. 10.1016/j.jpeds.2014.01.037.
36. Jackson M.L., Nelson J.C., Weiss N.S., Neuzil K.M., Barlow W., Jackson L.A. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008, 372:398-405. 10.1016/S0140-6736(08)61160-5.
37. Simonsen L., Viboud C., Taylor R.J., Miller M.A., Jackson L. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 2009, 27:6300-6304. 10.1016/j.vaccine.2009.07.008.
38. ®) during pregnancy and delivery outcome: a Swedish register study. BJOG 2012, 119:1583-1590. 10.1111/j.1471-0528.2012.03470.x.
39. SAGE Meeting of the Strategic Advisory Group of Experts on immunization, November 2013 - conclusions and recommendations. Wkly Epidemiol Rec 2014, 89:1-20.
40. Hernán M.A., Alonso A., Logan R., Grodstein F., Michels K.B., Willett W.C., et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 2008, 19:766-779. 10.1097/EDE.0b013e3181875e61.
41. Adegbola R., Nesin M., Wairagkar N. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am J Obstet Gynecol 2012, 207:S28-S32. 10.1016/j.ajog.2012.07.001.
42. Pasternak B., Svanström H., Mølgaard-Nielsen D., Krause T.G., Emborg H-D., Melbye M., et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 2012, 344:e2794. 10.1136/bmj.e2794.